BioSpace News Archive

Biotech Bay

NovaBay Pharmaceuticals Launches Avenova® Direct on Amazon.com

Original formulation of Avenova® for the management of bacterial dry eye is now available at an affordable price without a prescription

June 10, 2019
·
4 min read
Deals

/R E P E A T -- Canopy Growth to Announce Fourth Quarter and Fiscal Year 2019 Financial Results/

Canopy Growth Corporation will release its financial results for the fourth quarter and fiscal year ended March 31, 2019 after financial markets close on June 20, 2019.

June 10, 2019
·
4 min read
Deals

OTC Markets Group Welcomes NervGen Pharma to OTCQX

OTC Markets Group Inc. announced NervGen Pharma Corp., a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, has qualified to trade on the OTCQX® Best Market.

June 10, 2019
·
2 min read
Genetown

Tetraphase Pharmaceuticals Announces New XERAVA™ (eravacycline) Data at the 39th Annual Surgical Infection Society Meeting

Study Examines Microbiology and Hospitalization Outcomes Among Complicated Intra-Abdominal Infection Patients

June 10, 2019
·
11 min read
Business

Acceleron Announces Retirement of Director and Co-Founder Tom Maniatis

Acceleron Pharma Inc. announced that company co-founder Tom Maniatis, PhD, is retiring from his position on its Board of Directors and will continue to serve the organization in an advisory capacity as Director Emeritus.

June 10, 2019
·
3 min read
Deals

TherapeuticsMD to Host Investor and Analyst Day Today

TherapeuticsMD, Inc., an innovative, leading women’s healthcare company, will host its Investor and Analyst Day in New York City.

June 10, 2019
·
4 min read
Drug Development

Deciphera Pharmaceuticals, Inc. Expands Pipeline with Potential First-in-Class Autophagy Inhibitor to Treat Mutant RAS Cancers

Company to Host a Webcast on Tuesday, June 18, 2019 at 8 a.m. ET to Discuss Autophagy Inhibition and the Treatment of Mutant RAS Cancers

June 10, 2019
·
8 min read
Policy

Sesen Bio Announces Successful Pre-BLA Meeting with FDA for Vicinium®

Rolling Review of the BLA enables individual modules to be submitted and reviewed on an ongoing basis, rather than waiting for all sections to be completed before submission.

June 10, 2019
·
6 min read
Drug Development

Aerpio Initiates Phase 1b Clinical Trial of Topical Ocular Formulation of AKB-9778 for Primary Open Angle Glaucoma

Aerpio Pharmaceuticals, Inc. announced dosing of the first subject in a Phase 1b trial of a topical ocular formulation of AKB-9778 in development for treatment of primary open angle glaucoma.

June 10, 2019
·
2 min read
Business

GT Biopharma Company Update

GT Biopharma, Inc. an immuno-oncology company focused on innovative treatments based on the Company’s proprietary NK cell engager platform and Multi-Target Directed Bispecific Drug Conjugate platform, provided an update of the company’s drug development programs.

June 10, 2019
·
7 min read